CDEK
← All organizations

Indivior Inc.

For profitContributed to NMEWebsite ↗

Also known as: INDIVIOR | Indivior Inc. | INDIVIOR INC | Indivior, PLC.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Jun 1, 2014

First marketed drug

Jun 1, 2014

Last known activity

Sep 17, 2024

Timeline

1980s

  1. Dec 29, 1981

    buprenorphine— NDA Organization

2010s

  1. Jun 1, 2014

    Indivior Inc.— Founded

  2. Jul 27, 2018

    risperidone— Marketing Organization

  3. Jul 27, 2018

    risperidone— NDA Secondary Org

2020s

  1. Nov 14, 2022

    OpiantOpiant— Acquired

Drugs by trial phase (27 distinct, 57 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 1 (4 own, 1 via acquisition)

Other trials (3 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (4)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Richmond, VA, US Jun 1, 2014
Last known activity
Sep 17, 2024